Report ScoutReport Scout
Directory
Log in

Company Profile

Biomarin Pharmaceutical

BMRN

Biomarin Pharmaceutical is a Specialty Chemicals company in the Healthcare sector, headquartered in USA. This page tracks verified corporate disclosures including annual reports, ESG reports, sustainability filings, and financial statements.

The latest annual report from Biomarin Pharmaceutical tracked by Report Scout is the 2025 10-K report. In total, Report Scout tracks 2 verified Biomarin Pharmaceutical reports (2025), with verified links to the official PDF documents.

Subscribe to alerts for Biomarin Pharmaceutical

Country

USA

Exchange

Nasdaq

Sector

Healthcare

Industry

Specialty Chemicals

Archive

2 reports (2025)

Most Recent Report

Biomarin Pharmaceutical 2025 ESG

Published 2026-01-08

Download Biomarin Pharmaceutical 2025 ESG PDFView Biomarin Pharmaceutical 2025 ESG Web Page

Reports

2 total

Available reports

Annual reports, ESG disclosures, sustainability reports, financial filings, and other corporate documents published by Biomarin Pharmaceutical.

YEARS

2025

2 reports
ESG

Biomarin Pharmaceutical ESG 2025

Published 2026-01-08

Biomarin Pharmaceutical 2025 ESG PDFBiomarin Pharmaceutical 2025 ESG Web Page
10-K

Biomarin Pharmaceutical 10-K 2025

Published 2026-02-26

Biomarin Pharmaceutical 2025 10-K PDFBiomarin Pharmaceutical 2025 10-K Web Page

FAQ

Frequently asked questions

When was Biomarin Pharmaceutical's latest annual report published?

The most recent annual report from Biomarin Pharmaceutical tracked by Report Scout is the 2025 10-K report, published 2026-02-26. New filings are added automatically once discovered and verified.

Where can I download Biomarin Pharmaceutical's reports as PDF?

This page lists 2 verified Biomarin Pharmaceutical reports (2025) with direct links to the official PDF documents published by the company.

Does Report Scout track Biomarin Pharmaceutical's sustainability and ESG reports?

Yes. Report Scout tracks 1 sustainability-related report from Biomarin Pharmaceutical — the most recent is the 2025 ESG report.